JP2015531873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015531873A5 JP2015531873A5 JP2015531492A JP2015531492A JP2015531873A5 JP 2015531873 A5 JP2015531873 A5 JP 2015531873A5 JP 2015531492 A JP2015531492 A JP 2015531492A JP 2015531492 A JP2015531492 A JP 2015531492A JP 2015531873 A5 JP2015531873 A5 JP 2015531873A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- subject
- sample
- fgf
- specifically binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12184085 | 2012-09-12 | ||
| EP12184085.4 | 2012-09-12 | ||
| PCT/EP2013/056706 WO2014040759A1 (en) | 2012-09-12 | 2013-03-28 | Identification of patients with abnormal fractional shortening |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017220660A Division JP6615848B2 (ja) | 2012-09-12 | 2017-11-16 | 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015531873A JP2015531873A (ja) | 2015-11-05 |
| JP2015531873A5 true JP2015531873A5 (https=) | 2016-05-19 |
| JP6247302B2 JP6247302B2 (ja) | 2017-12-13 |
Family
ID=46826365
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531492A Active JP6247302B2 (ja) | 2012-09-12 | 2013-03-28 | 異常な短縮率（ｆｒａｃｔｉｏｎａｌｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定 |
| JP2017220660A Active JP6615848B2 (ja) | 2012-09-12 | 2017-11-16 | 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017220660A Active JP6615848B2 (ja) | 2012-09-12 | 2017-11-16 | 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20150185230A1 (https=) |
| EP (3) | EP2895866B1 (https=) |
| JP (2) | JP6247302B2 (https=) |
| CN (1) | CN104620111B (https=) |
| CA (1) | CA2883890C (https=) |
| ES (2) | ES2913539T3 (https=) |
| WO (1) | WO2014040759A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103998938B (zh) | 2011-10-17 | 2016-06-15 | 霍夫曼-拉罗奇有限公司 | 风险患者和中风原因的基于肌钙蛋白和bnp的诊断 |
| EP2924438B1 (en) | 2014-03-26 | 2018-04-18 | Roche Diagnostics GmbH | IGFBP7 for diagnosing diastolic dysfunction |
| CN107110871B (zh) | 2014-10-29 | 2019-09-27 | 豪夫迈·罗氏有限公司 | 用于死亡的风险预测的生物标志物 |
| JP6859334B2 (ja) | 2015-10-08 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 手術前に測定した際にａｋｉのリスクを予測するためのｉｇｆｂｐ７ |
| WO2017125406A1 (en) * | 2016-01-19 | 2017-07-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting left ventricular remodeling in subjects suffering from hypertension |
| JP7269182B2 (ja) * | 2017-05-30 | 2023-05-08 | アボット・ラボラトリーズ | 心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法 |
| CN111480081A (zh) | 2017-12-13 | 2020-07-31 | 豪夫迈·罗氏有限公司 | 用于预测脑卒中的循环血管生成素-2(Ang-2)和胰岛素样生长因子结合蛋白7(IGFBP7) |
| JP7024576B2 (ja) * | 2018-04-20 | 2022-02-24 | オムロンヘルスケア株式会社 | 電子血圧計および心不全検出器 |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US20250232875A1 (en) * | 2022-03-18 | 2025-07-17 | Roche Diagnostics Operations, Inc. | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| US12333413B1 (en) * | 2024-03-01 | 2025-06-17 | Mayo Foundation For Medical Education And Research | Apparatus and method for training an artificial intelligence-supported diagnostic assessment tool |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
| US6709855B1 (en) | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
| JP2004532202A (ja) * | 2001-03-15 | 2004-10-21 | シアオ，ヨング−フー | 生存哺乳動物における臨床的に認められた形態の心臓の病状を治療的に処置する方法 |
| US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| EP1322957B1 (en) * | 2001-05-04 | 2009-08-12 | Biosite Incorporated | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| US20050095646A1 (en) * | 2001-11-19 | 2005-05-05 | Sherman Michael I. | Method of using a non-antibody protein to detect and measure an analyte |
| JP2005291899A (ja) * | 2004-03-31 | 2005-10-20 | Akira Matsumori | 心疾患の検査法 |
| US8563328B2 (en) * | 2004-07-26 | 2013-10-22 | University Of Louisville Research Foundation, Inc. | Fiber-optic biosensor and biosensing methods |
| US20080027330A1 (en) * | 2006-05-15 | 2008-01-31 | Endothelix, Inc. | Risk assessment method for acute cardiovascular events |
| WO2008060618A2 (en) * | 2006-11-15 | 2008-05-22 | University Of Florida Research Foundation | Use of genetic determinants in cardiovascular risk assessment |
| CN106908603B (zh) * | 2007-01-25 | 2019-04-02 | 霍夫曼-拉罗奇有限公司 | Igfbp-7在心力衰竭评估中的用途 |
| WO2008134054A1 (en) * | 2007-04-26 | 2008-11-06 | Genera Doo | Blood biomarkers for bone fracture and cartilage injury |
| EP2515116A1 (en) | 2007-05-18 | 2012-10-24 | Duke University | Serum biomarkers for the early detection of lung cancer |
| WO2009091556A2 (en) * | 2008-01-17 | 2009-07-23 | The General Hospital Corporation | Diagnostic methods and kits using fibroblast growth factor-23 |
| AU2009313561A1 (en) * | 2008-11-06 | 2011-06-30 | Musc Foundation For Research Development | Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers |
| BRPI1006780A2 (pt) | 2009-04-01 | 2019-03-26 | Lek Pharmaceuticals D. D. | processo para preparar um composto, processo para a preparação de 3-amino-2, 2-dimetilpropanamida,processo para preparar um agente terapêutico, profilático ou de diagnóstico, processo para preparar alisquireno, processo para preparar um derivado de criptoficina,uso de um composto,uso de 3-amino-2,2-dimetilpropanamida e uso de agente terapêutico,profilático ou de diagnóstico. |
| CN102422157B (zh) | 2009-04-27 | 2014-10-29 | 霍夫曼-拉罗奇有限公司 | 内皮抑制素作为心力衰竭标记的应用 |
| CN102549436A (zh) | 2009-07-27 | 2012-07-04 | 霍夫曼-拉罗奇有限公司 | mimecan在评价心力衰竭中的用途 |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| JP6092092B2 (ja) * | 2010-03-26 | 2017-03-08 | マイカーティス エヌ．ヴェ．ＭｙＣａｒｔｉｓ ＮＶ | 腎機能障害、糸球体濾過速度、呼吸困難、急性心不全、左心室肥大、心線維症、子癇前症、妊娠関連蛋白尿のバイオマーカーとしてのｌｔｂｐ２ |
| US20120142632A1 (en) * | 2010-08-04 | 2012-06-07 | St. Vincent's Institute Of Medical Research | Diagnostic and prognostic assay |
| CN108387744A (zh) | 2010-08-26 | 2018-08-10 | 弗·哈夫曼-拉罗切有限公司 | 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途 |
| US10422796B2 (en) * | 2010-08-31 | 2019-09-24 | Kyowa Medex Co., Ltd. | Method for measuring fibroblast growth factor-23 and reagent therefor |
-
2013
- 2013-03-28 CN CN201380047272.0A patent/CN104620111B/zh active Active
- 2013-03-28 ES ES18174585T patent/ES2913539T3/es active Active
- 2013-03-28 EP EP13713175.1A patent/EP2895866B1/en active Active
- 2013-03-28 CA CA2883890A patent/CA2883890C/en active Active
- 2013-03-28 ES ES13713175.1T patent/ES2680149T3/es active Active
- 2013-03-28 EP EP22161423.3A patent/EP4075143A1/en active Pending
- 2013-03-28 WO PCT/EP2013/056706 patent/WO2014040759A1/en not_active Ceased
- 2013-03-28 JP JP2015531492A patent/JP6247302B2/ja active Active
- 2013-03-28 EP EP18174585.2A patent/EP3428649B1/en active Active
-
2015
- 2015-03-11 US US14/644,695 patent/US20150185230A1/en not_active Abandoned
-
2017
- 2017-11-16 JP JP2017220660A patent/JP6615848B2/ja active Active
-
2018
- 2018-03-05 US US15/911,699 patent/US11454634B2/en active Active
-
2022
- 2022-08-19 US US17/891,458 patent/US20220412991A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015531873A5 (https=) | ||
| Winau et al. | High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus | |
| Imran et al. | Native T1 mapping in the diagnosis of cardiac allograft rejection: a prospective histologically validated study | |
| Heberton et al. | Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation | |
| Klok et al. | External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism | |
| Andruchow et al. | Contemporary emergency department management of patients with chest pain: a concise review and guide for the high-sensitivity troponin era | |
| Rusconi et al. | Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure | |
| Jing et al. | Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children | |
| Ray et al. | Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension | |
| Mather et al. | Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance | |
| Mayr et al. | Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study | |
| Gawor et al. | Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance | |
| JP2015504519A5 (https=) | ||
| Kobayashi et al. | Urinary 8-hydroxy-2′-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis | |
| Ross et al. | Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review | |
| CN109891243A (zh) | 心房纤颤和中风的评价中的循环esm-1 (endocan) | |
| Deraz et al. | Assessment of ventricular dysfunction in Egyptian children with Beta-thalassemia major | |
| Ungar et al. | A preliminary 18F-FDG-PET/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis | |
| Schaaf et al. | Which high-sensitivity troponin variable best characterizes infarct size and microvascular obstruction? | |
| Yamasaki et al. | Clinical impact of left ventricular eccentricity index using cardiac MRI in assessment of right ventricular hemodynamics and myocardial fibrosis in congenital heart disease | |
| Fairley et al. | Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis | |
| JP2015004664A (ja) | アルツハイマー病罹患リスクを検出する方法 | |
| Casals et al. | Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction | |
| He et al. | Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: a cardiac MR study | |
| Hanneman et al. | Cardiovascular CT in the diagnosis of pericardial constriction: predictive value of inferior vena cava cross-sectional area |